Pill Box

Friday, June 24, 2005


Recalls of popular drugs like Vioxx and Celebrex raise questions about how smart it is for drug companies to bypass doctors and hawk their wares directly to consumers on TV. Some claim the $4 billion spent annually on the ads increase awareness of treatments; others say the result is an overmedicated public clamoring for pills. Brooke consults with Jim Davidson, counsel to the Advertising Coalition, about the ethics of direct-to-consumer ads.

Leave a Comment

Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.